Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and Equipment
Growth Metrics
Income Statement
Others
Ratios

Takeda Pharmaceutical (TKPHF) Change in Intangibles (2018 - 2025)

Historic Change in Intangibles for Takeda Pharmaceutical (TKPHF) over the last 8 years, with Q4 2025 value amounting to -$1.2 billion.

  • Takeda Pharmaceutical's Change in Intangibles fell 142145.67% to -$1.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$1.7 billion, marking a year-over-year decrease of 11467.3%. This contributed to the annual value of -$965.3 million for FY2025, which is 5440.2% up from last year.
  • Latest data reveals that Takeda Pharmaceutical reported Change in Intangibles of -$1.2 billion as of Q4 2025, which was down 142145.67% from -$86.4 million recorded in Q3 2025.
  • In the past 5 years, Takeda Pharmaceutical's Change in Intangibles registered a high of -$75.1 million during Q3 2024, and its lowest value of -$3.1 billion during Q1 2023.
  • Moreover, its 5-year median value for Change in Intangibles was -$187.8 million (2021), whereas its average is -$478.7 million.
  • As far as peak fluctuations go, Takeda Pharmaceutical's Change in Intangibles plummeted by 210838.23% in 2023, and later soared by 9567.39% in 2024.
  • Over the past 5 years, Takeda Pharmaceutical's Change in Intangibles (Quarter) stood at -$187.9 million in 2021, then skyrocketed by 35.36% to -$121.5 million in 2022, then plummeted by 67.35% to -$203.3 million in 2023, then soared by 62.58% to -$76.1 million in 2024, then plummeted by 1421.46% to -$1.2 billion in 2025.
  • Its last three reported values are -$1.2 billion in Q4 2025, -$86.4 million for Q3 2025, and -$187.7 million during Q2 2025.